Search research articles
Contact Us
Filters
Showing results (31-40 of 65) with videos related to
Page
of 7
Sort By:
Cancer Chemotherapy and Pharmacology
|
July 26, 2020
Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancer
Yosuke Kito, Hironaga Satake, Hiroya Taniguchi, et al.
Journal of the National Cancer Institute
|
May 18, 2022
The Molecular Landscape of Pancreatobiliary Cancers for Novel Targeted Therapies From Real-World Genomic Profiling
Kumiko Umemoto, Hiroyuki Yamamoto, Ritsuko Oikawa, et al.
World Journal of Gastrointestinal Oncology
|
November 30, 2020
Inferior mesenteric arteriovenous fistula during treatment with bevacizumab in colorectal cancer patient: A case report
Ayako Doi, Hiroyuki Takeda, Kumiko Umemoto, et al.
Investigational New Drugs
|
August 6, 2022
Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors
Toshio Shimizu, Takako Eguchi Nakajima, Noboru Yamamoto, et al.
Targeted Oncology
|
April 13, 2024
The Molecular Landscape of Gastric Cancers for Novel Targeted Therapies from Real-World Genomic Profiling
Hiroyuki Yamamoto, Hiroyuki Arai, Ritsuko Oikawa, et al.
Targeted Oncology
|
September 5, 2023
Real-World Treatment Sequencing in Vulnerable Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Study
Seiichiro Mitani, Yosuke Kito, Kaori Hino, et al.
International Journal of Clinical Oncology
|
June 27, 2023
Phase II clinical trial to study the safety and efficacy of combined S-1 + oxaliplatin therapy as neoadjuvant chemotherapy for locally advanced gastric cancer in older patients
Mitsuhiko Ota, Hiroshi Saeki, Hideo Uehara, et al.
BMC Cancer
|
October 30, 2021
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer
Shun Yamamoto, Kengo Nagashima, Takeshi Kawakami, et al.
Future Oncology (London, England)
|
June 6, 2025
A multicenter Phase II study of mFOLFOX6 plus nivolumab for gastric cancer with severe peritoneal metastases: WJOG16322G
Munehiro Wakabayashi, Toshiki Masuishi, Takatsugu Ogata, et al.
JCO Precision Oncology
|
August 8, 2024
Genomic Profiling of Small Intestine Cancers From a Real-World Data Set Identifies Subgroups With Actionable Alterations
Hiroyuki Takeda, Hiroyuki Yamamoto, Ritsuko Oikawa, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 65) with videos related to
Sort By:
Page
of 7
Cancer Chemotherapy and Pharmacology
|
July 26, 2020
Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancer
Yosuke Kito, Hironaga Satake, Hiroya Taniguchi, et al.
Journal of the National Cancer Institute
|
May 18, 2022
The Molecular Landscape of Pancreatobiliary Cancers for Novel Targeted Therapies From Real-World Genomic Profiling
Kumiko Umemoto, Hiroyuki Yamamoto, Ritsuko Oikawa, et al.
World Journal of Gastrointestinal Oncology
|
November 30, 2020
Inferior mesenteric arteriovenous fistula during treatment with bevacizumab in colorectal cancer patient: A case report
Ayako Doi, Hiroyuki Takeda, Kumiko Umemoto, et al.
Investigational New Drugs
|
August 6, 2022
Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors
Toshio Shimizu, Takako Eguchi Nakajima, Noboru Yamamoto, et al.
Targeted Oncology
|
April 13, 2024
The Molecular Landscape of Gastric Cancers for Novel Targeted Therapies from Real-World Genomic Profiling
Hiroyuki Yamamoto, Hiroyuki Arai, Ritsuko Oikawa, et al.
Targeted Oncology
|
September 5, 2023
Real-World Treatment Sequencing in Vulnerable Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Study
Seiichiro Mitani, Yosuke Kito, Kaori Hino, et al.
International Journal of Clinical Oncology
|
June 27, 2023
Phase II clinical trial to study the safety and efficacy of combined S-1 + oxaliplatin therapy as neoadjuvant chemotherapy for locally advanced gastric cancer in older patients
Mitsuhiko Ota, Hiroshi Saeki, Hideo Uehara, et al.
BMC Cancer
|
October 30, 2021
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer
Shun Yamamoto, Kengo Nagashima, Takeshi Kawakami, et al.
Future Oncology (London, England)
|
June 6, 2025
A multicenter Phase II study of mFOLFOX6 plus nivolumab for gastric cancer with severe peritoneal metastases: WJOG16322G
Munehiro Wakabayashi, Toshiki Masuishi, Takatsugu Ogata, et al.
JCO Precision Oncology
|
August 8, 2024
Genomic Profiling of Small Intestine Cancers From a Real-World Data Set Identifies Subgroups With Actionable Alterations
Hiroyuki Takeda, Hiroyuki Yamamoto, Ritsuko Oikawa, et al.
Page
of 7